{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:19:41Z","timestamp":1791231581281,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502325"],"award-info":[{"award-number":["81502325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672658"],"award-info":[{"award-number":["81672658"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12094-019-02090-2","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T16:35:47Z","timestamp":1554741347000},"page":"1624-1633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma"],"prefix":"10.1007","volume":"21","author":[{"given":"L.","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-4396","authenticated-orcid":false,"given":"Z.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"2090_CR1","volume-title":"Soft tissue tumours","author":"FM Enzinger","year":"2001","unstructured":"Enzinger FM, Weiss SW. Soft tissue tumours. Chicago: Mosby, Inc; 2001."},{"key":"2090_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/01.mph.0000161764.60798.60","volume":"27","author":"RB Raney","year":"2005","unstructured":"Raney RB. Synovial sarcoma in young people: background, prognostic factors, and therapeutic questions. J Pediatr Hematol Oncol. 2005;27:207\u201311.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2090_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0093-7754(01)90099-5","volume":"28","author":"GD Demetri","year":"2001","unstructured":"Demetri GD. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. Semin Oncol. 2001;28:19\u201326.","journal-title":"Semin Oncol"},{"key":"2090_CR4","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1200\/JCO.2002.20.17.3568","volume":"20","author":"CL Sawyers","year":"2002","unstructured":"Sawyers CL. Imatinib GIST keeps finding new indications: successful treatment of dermatofibrosarcoma protuberans by targeted inhibition of the platelet-derived growth factor receptor. J Clin Oncol. 2002;20:3568\u20139.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2090_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1200\/JCO.2005.06.124","volume":"23","author":"D Strumberg","year":"2005","unstructured":"Strumberg D, Richly H, Hilger RA, Schleucher N, Korfee S, Tewes M, Faghih M, Brendel E, Voliotis D, Haase CG, Schwartz B, Awada A, Voigtmann R, Scheulen ME, Seeber S. Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. J Clin Oncol. 2005;23(5):965\u201372.","journal-title":"J Clin Oncol"},{"issue":"9","key":"2090_CR6","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1158\/1078-0432.CCR-11-1900","volume":"18","author":"K Mross","year":"2012","unstructured":"Mross K, Frost A, Steinbild S, Hedbom S, B\u00fcchert M, Fasol U, Unger C, Kr\u00e4tzschmar J, Heinig R, Boix O, Christensen O. A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors. Clin Cancer Res. 2012;18(9):2658\u201367.","journal-title":"Clin Cancer Res"},{"issue":"14","key":"2090_CR7","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.4155\/fmc.12.121","volume":"4","author":"L Huang","year":"2012","unstructured":"Huang L, Huang Z, Bai Z, Xie R, Sun L, Lin K. Development and strategies of VEGFR-2\/KDR inhibitors. Future Med Chem. 2012;4(14):1839\u201352.","journal-title":"Future Med Chem"},{"issue":"1","key":"2090_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13045-016-0332-8","volume":"9","author":"Y Sun","year":"2016","unstructured":"Sun Y, Niu W, Du F, Du C, Li S, Wang J, Li L, Wang F, Hao Y, Li C, Chi Y. Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors. J Hematol Oncol. 2016;9(1):105.","journal-title":"J Hematol Oncol"},{"key":"2090_CR9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12885-015-1635-9","volume":"15","author":"H Salim","year":"2015","unstructured":"Salim H, Zong D, Haag P, Novak M, Mork B, Lewensohn R, Lundholm L, Viktorsson K. Dkk1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines. BMC Cancer. 2015;15:628.","journal-title":"BMC Cancer"},{"issue":"9","key":"2090_CR10","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1101\/gad.1065903","volume":"17","author":"Y Takayama","year":"2003","unstructured":"Takayama Y, Kamimura Y, Okawa M, Muramatsu S, Sugino A, Araki HGINS. a novel multiprotein complex required for chromosomal DNA replication in budding yeast. Genes Dev. 2003;17(9):1153\u201365.","journal-title":"Genes Dev"},{"key":"2090_CR11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2443.2007.01090.x","volume":"12","author":"C Bauerschmidt","year":"2007","unstructured":"Bauerschmidt C, Pollok S, Kremmer E, Nasheuer HP, Grosse F. Interactions of human Cdc45 with the Mcm2-7 complex, the GINS complex, and DNA polymerases delta and epsilon during S phase. Genes Cells. 2007;12:745\u201358.","journal-title":"Genes Cells"},{"key":"2090_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/ncb1382","volume":"8","author":"A Gambus","year":"2006","unstructured":"Gambus A, Jones RC, Sanchez-Diaz A, Kanemaki K, van Deursen F, Edmondson RD, Labib K. GINS maintains association of Cdc45 with MCM in replisome progression complexes at eukaryotic DNA replication forks. Nat Cell Biol. 2006;8:358\u201366.","journal-title":"Nat Cell Biol"},{"key":"2090_CR13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature01692","volume":"423","author":"M Kanemaki","year":"2003","unstructured":"Kanemaki M, Sanchez-Diaz A, Gambus A, Labib K. Functional proteomic identification of DNA replication proteins by induced proteolysis in vivo. Nature. 2003;423:720\u20134.","journal-title":"Nature"},{"key":"2090_CR14","doi-asserted-by":"publisher","first-page":"10236","DOI":"10.1073\/pnas.0602400103","volume":"103","author":"SE Moyer","year":"2006","unstructured":"Moyer SE, Lewis PW, Botchan MR. Isolation of the Cdc45\/Mcm2-7\/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase. Proc Natl Acad Sci. 2006;103:10236\u201341.","journal-title":"Proc Natl Acad Sci"},{"key":"2090_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.molcel.2006.01.030","volume":"21","author":"M Pacek","year":"2006","unstructured":"Pacek M, Tutter AV, Kubota Y, Takisawa H, Walter JC. Localization of MCM2-7, Cdc45, and GINS to the site of DNA unwinding during eukaryotic DNA replication. Mol Cell. 2006;21:581\u20137.","journal-title":"Mol Cell"},{"issue":"23","key":"2090_CR16","doi-asserted-by":"publisher","first-page":"10528","DOI":"10.1128\/MCB.25.23.10528-10532.2005","volume":"25","author":"M Ueno","year":"2005","unstructured":"Ueno M, Itoh M, Kong L, Sugihara K, Asano M, Takakura N. PSF1 is essential for early embryogenesis in mice. Mol Cell Biol. 2005;25(23):10528\u201332.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2090_CR17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1365-2443.2010.01442.x","volume":"15","author":"I Nakahara","year":"2010","unstructured":"Nakahara I, Miyamoto M, Shibata T, Akashi-Tanaka S, Kinoshita T, Mogushi K, Oda K, Ueno M, Takakura N, Mizushima H, Tanaka H, Ohta T. Up-regulation of PSF1 promotes the growth of breast cancer cells. Genes Cells. 2010;15(10):1015\u201324.","journal-title":"Genes Cells"},{"issue":"1","key":"2090_CR18","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.5301\/jbm.5000105","volume":"30","author":"L Zhou","year":"2015","unstructured":"Zhou L, Sun XJ, Liu C, Wu QF, Tai MH, Wei JC, Lei L, Meng FD, Qu K, Xu J. Overexpression of PSF1 is correlated with poor prognosis in hepatocellular carcinoma patients. Int J Biol Markers. 2015;30(1):e56\u201364.","journal-title":"Int J Biol Markers"},{"issue":"3","key":"2090_CR19","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s13277-014-2826-8","volume":"36","author":"J Zhang","year":"2015","unstructured":"Zhang J, Wu Q, Wang Z, Zhang Y, Zhang G, Fu J, Liu C. Knockdown of PSF1 expression inhibits cell proliferation in lung cancer cells in vitro. Tumour Biol. 2015;36(3):2163\u20138.","journal-title":"Tumour Biol"},{"issue":"1","key":"2090_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/pcan.2014.46","volume":"18","author":"H Tahara","year":"2015","unstructured":"Tahara H, Naito H, Kise K, Wakabayashi T, Kamoi K, Okihara K, Yanagisawa A, Nakai Y, Nonomura N, Morii E, Miki T, Takakura N. Evaluation of PSF1 as a prognostic biomarker for prostate cancer. Prostate Cancer Prostatic Dis. 2015;18(1):56\u201362.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"2090_CR21","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1245\/s10434-016-5392-z","volume":"23","author":"R Kanzaki","year":"2016","unstructured":"Kanzaki R, Naito H, Kise K, Takara K, Eino D, Minami M, Shintani Y, Funaki S, Kawamura T, Kimura T, Okumura M, Takakura N. PSF1 (Partner of SLD Five 1) is a Prognostic biomarker in patients with non-small cell lung cancer treated with surgery following preoperative chemotherapy or chemoradiotherapy. Ann Surg Oncol. 2016;23(12):4093\u2013100.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"2090_CR22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1158\/0008-5472.CAN-09-3662","volume":"70","author":"Y Nagahama","year":"2010","unstructured":"Nagahama Y, Ueno M, Miyamoto S, Morii E, Minami T, Mochizuki N, Saya H. Takakura N.PSF1, a DNA replication factor expressed widely in stem and progenitor cells, drives tumorigenic and metastatic properties. Cancer Res. 2010;70(3):1215\u201324.","journal-title":"Cancer Res"},{"key":"2090_CR23","doi-asserted-by":"publisher","first-page":"13555","DOI":"10.1073\/pnas.95.23.13555","volume":"95","author":"HB Sun","year":"1998","unstructured":"Sun HB, Zhu YX, Yin T, Sledge G, Yang YC. MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity. Proc Natl Acad Sci USA. 1998;95:13555\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2090_CR24","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1016\/j.febslet.2007.11.072","volume":"581","author":"L Bai","year":"2007","unstructured":"Bai L, Merchant JL. A role for CITED2, a CBP\/p300 interacting protein, in colon cancer cell invasion. FEBS Lett. 2007;581:5904\u201310.","journal-title":"FEBS Lett"},{"issue":"13","key":"2090_CR25","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1073\/pnas.94.13.6948","volume":"94","author":"N Zhao","year":"1997","unstructured":"Zhao N, Stoffel A, Wang PW, Eisenbart JD, Espinosa R, Larson RA, et al. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1\u20131.5\u00a0Mb and preparation of a PAC-based physical map. Proc Natl Acad Sci USA. 1997;94(13):6948\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2090_CR26","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.4049\/jimmunol.181.7.4590","volume":"181","author":"M Gururajan","year":"2008","unstructured":"Gururajan M, Simmons A, Dasu T, Spear BT, Calulot C, Robertson DA, et al. Early growth response genes regulate B cell development, proliferation, and immune response. J Immunol. 2008;181(7):4590\u2013602.","journal-title":"J Immunol"},{"key":"2090_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.semcdb.2003.12.022","volume":"15","author":"A Mora","year":"2004","unstructured":"Mora A, Komander D, Van Aalten DMF, Alessi DR. PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol. 2004;15:161\u201370.","journal-title":"Semin Cell Dev Biol"},{"issue":"5","key":"2090_CR28","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1159\/000447885","volume":"39","author":"C Talarico","year":"2016","unstructured":"Talarico C, Dattilo V, D\u2019Antona L, Menniti M, Bianco C, Ortuso F, Alcaro S, Schenone S, Perrotti N, Amato R. SGK1, the new player in the game of resistance: chemo-radio molecular target and strategy for inhibition. Cell Physiol Biochem. 2016;39(5):1863\u201376.","journal-title":"Cell Physiol Biochem"},{"key":"2090_CR29","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1111\/j.1582-4934.2010.01115.x","volume":"14","author":"PH Anborgh","year":"2010","unstructured":"Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med. 2010;14:2037\u201344.","journal-title":"J Cell Mol Med"},{"key":"2090_CR30","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/sj.bjc.6601839","volume":"90","author":"SR Rittling","year":"2004","unstructured":"Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer. 2004;90:1877\u201381.","journal-title":"Br J Cancer"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02090-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-019-02090-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02090-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T18:43:37Z","timestamp":1721155417000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-019-02090-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2090"],"URL":"https:\/\/doi.org\/10.1007\/s12094-019-02090-2","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"9 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. In this study, the Ethics Committees of Affiliated Sixth People\u2019s Hospital, Shanghai Jiaotong University have approved all studies about human participants and animal experiments. All participants have written informed consents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}